論文業績

  1. Yabuuchi Y, Yoshida M, Kakushima N, Kato M, Iguchi M, Yamamoto Y, Kanetaka K, Uraoka T, Fujishiro M, Sho M; Japan Duodenal Cancer Committee.
    Risk Factors for Non-Ampullary Duodenal Adenocarcinoma: A Systematic Review.
    Dig Dis. 2022;40(2):147-155.
  2. Zuo S, Sawai T, Kanehiro H, Kuroda Y, Sho M.
    Gallstones in patients with severe motor and intellectual disability.
    Pediatr Int. 2022 Jan;64(1):e15220.
  3. Gemenetzis G, Blair AB, Nagai M, Groot VP, Ding D, Javed AA, Burkhart RA, Fishman EK, Hruban RH, Weiss MJ, Cameron JL, Narang A, Laheru D, Lafaro K, Herman JM, Zheng L, Burns WR 3rd, Wolfgang CL, He J.
    Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer.
    Ann Surg Oncol. 2022 Jan;29(1):401-414.
  4. Obara S, Koyama F, Kuge H, Nakamoto T, Ikeda N, Iwasa Y, Takei T, Sadamitsu T, Fujimoto K, Harada S, Sho M.
    Effect of preoperative asymptomatic renal dysfunction on the clinical course after colectomy for colon cancer.
    Surg Today. 2022 Jan;52(1):106-113.
  5. Nakamoto T, Koyama F, Kuge H, Obara S, Ikeda N, Iwasa Y, Takei T, Sadamitsu T, Harada S, Fujimoto K, Inoue T, Hatakeyama K, Ohbayashi C, Sho M.
    In vitro analysis of exfoliated tumor cells in intraluminal lavage samples after colorectal endoscopic submucosal dissection.
    Int J Colorectal Dis. 2022 Jan;37(1):161-170.
  6. Sukegawa M, Nishiwada S, Terai T, Kuge H, Koyama F, Nakagawa K, Nagai M, Sho M.
    Acute superior mesenteric artery occlusion associated with COVID-19 pneumonia: a case report.
    Surg Case Rep. 2022 Jan 10;8(1):6.
  7. Nakagawa K, Sho M, Okada KI, Akahori T, Aoyama T, Eguchi H, Fujii T, Higuchi R, Kanaji S, Kanetaka K, Kuroda S, Nagakawa Y, Nunobe S, Yamada S, Yamashita H, Yamaue H, Kodera Y; Japan Duodenal Cancer Guideline Committee.
    Surgical results of non-ampullary duodenal cancer: a nationwide survey in Japan.
    J Gastroenterol. 2022 Feb;57(2):70-81.
  8. Sekita-Hatakeyama Y, Fujii T, Nishikawa T, Mitoro A, Sawai M, Itami H, Morita K, Uchiyama T, Takeda M, Sho M, Yoshiji H, Hatakeyama K, Ohbayashi C.
    Evaluation and diagnostic value of next-generation sequencing analysis of residual liquid-based cytology specimens of pancreatic masses.
    Cancer Cytopathol. 2022 Mar;130(3):202-214.
  9. Sawai T, Zuo S, Terai T, Nishiwada S, Nakagawa K, Nagai M, Akahori T, Kanehiro H, Sho M.
    Nonalcoholic fatty liver disease developed after pancreatoduodenectomy for solid pseudopapillary neoplasm in a 10-year-old girl: a case report.
    Surg Case Rep. 2022 Apr 6;8(1):61.
  10. Homma Y, Endo I, Matsuyama R, Sho M, Mizuno S, Seyama Y, Hirano S, Aono T, Kitami C, Morita Y, Takeda Y, Yoshida K, Tani M, Kaiho T, Yamamoto Y, Aoki H, Ogawa M, Niguma T, Mataki Y, Kawasaki H, Baba H, Yokomizo H, Rikiyama T, Yamaue H, Yamamoto M.
    Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis.
    J Hepatobiliary Pancreat Sci. 2022 May;29(5):552-561.
  11. Kawaguchi C, Hokuto D, Yasuda S, Yoshikawa T, Kamitani N, Matsuo Y, Sho M.
    Advantages of skin closure with subcuticular suture for liver resection on postoperative and cosmetic outcomes: a propensity matched analysis.
    Langenbecks Arch Surg. 2022 May;407(3):1121-1129.
  12. Matsumoto S, Wakatsuki K, Nakade H, Kunishige T, Miyao S, Tsujimoto A, Tatsumi T, Sho M.
    Impact of CT-assessed changes in tumor size after neoadjuvant chemotherapy on pathological response and survival of patients with esophageal squamous cell carcinoma.
    Langenbecks Arch Surg. 2022 May;407(3):965-974.
  13. Sasaki T, Nishiwada S, Nakagawa K, Nagai M, Terai T, Hokuto D, Yasuda S, Matsuo Y, Doi S, Sho M.
    Integrative analysis identifies activated anti-tumor immune microenvironment in lung metastasis of pancreatic cancer.
    Int J Clin Oncol. 2022 May;27(5):948-957.
  14. Nagai M, Nakagawa K, Nishiwada S, Terai T, Hokuto D, Yasuda S, Matsuo Y, Doi S, Akahori T, Sho M.
    Clinically Relevant Late-Onset Biliary Complications After Pancreatoduodenectomy.
    World J Surg. 2022 Jun;46(6):1465-1473.
  15. Kunisaki C, Yoshida K, Yoshida M, Matsumoto S, Arigami T, Sugiyama Y, Seto Y, Akiyama Y, Oshio A, Nakada K.
    Effects of Proximal Gastrectomy and Various Clinical Factors on Postoperative Quality of Life for Upper-Third Gastric Cancer Assessed Using the Postgastrectomy Syndrome Assessment Scale-45 (PGSAS-45): A PGSAS NEXT Study．
    Ann Surg Oncol. 2022 Jun;29(6):3899-3908.
  16. Takei T, Koyama F, Iwasa Y, Kuge H, Sho M.
    Endoscopic treatment for appendiceal intussusception due to barium stool impaction that mimics a submucosal tumor.
    Tech Coloproctol. 2022 Jul;26(7):595-596.
  17. Sasaki T, Yang CY, Nakagawa K, Nagai M, Nishiwada S, Terai T, Sho M.
    Safety and Feasibility of Single-incision Laparoscopic Distal Pancreatectomy.
    Surg Laparosc Endosc Percutan Tech. 2022 Aug 1;32(4):488-493.
  18. Kunishige T, Migita K, Matsumoto S, Wakatsuki K, Nakade H, Aoki S, Miyao S, Tatsumi T, Tsujimoto A, Sho M.
    The Prognostic Significance of Preoperative Anemia in Gastric Cancer Patients.
    In Vivo. 2022 Sep-Oct;36(5):2314-2322.
  19. Takagi T, Nagai M, Nishiwada S, Terai T, Yasuda S, Matsuo Y, Doi S, Kohara Y, Sho M.
    Importance of triple tumor markers as biomarkers in patients with pancreatic ductal adenocarcinoma.
    Ann Gastroenterol Surg. 2022 Oct 11;7(2):326-335.
  20. Matsuo Y, Hokuto D, Yasuda S, Yoshikawa T, Kamitani N, Doi S, Nakagawa K, Nishiwada S, Nagai M, Terai T, Sho M.
    Impact of laparoscopic liver resection on liver regeneration.
    Surg Endosc. 2022 Oct;36(10):7419-7430.
  21. Narita H, Kawaratani H, Shibamoto A, Takeda S, Ozutsumi T, Tsuji Y, Fujinaga Y, Kitagawa K, Nishimura N, Hokuto D, Sho M, Yoshiji H.
    Long-term survival with sorafenib-based multidisciplinary treatment for Vp4 hepatocellular carcinoma: a case report.
    Clin J Gastroenterol. 2022 Oct;15(5):953-959.
  22. Matsumoto Y, Koyama F, Morita K, Kuge H, Obara S, Iwasa Y, Takei T, Sadamitsu T, Ohbayashi C, Sho M.
    A case of Cronkhite-Canada syndrome with repeated linked color imaging observation of the subepithelial capillary network in the colon.
    Clin J Gastroenterol. 2022 Oct;15(5):934-940.
  23. Minamiguchi K, Marugami N, Uchiyama T, Kusano H, Yasuda S, Sho M, Tanaka T.
    Imaging features of β-catenin-activated hepatocellular adenoma with weak β-catenin activation: A rare case report.
    Acta Radiol Open. 2022 Nov 23;11(11):20584601221142241.
  24. Sadamitsu T, Koyama F, Tanaka T, Kuge H, Sho M.
    A case of coil migration into the colon after embolization of the spleno-renal shunt.
    Tech Coloproctol. 2022 Nov;26(11):923-924.
  25. Fujimoto K, Koyama F, Kuge H, Obara S, Iwasa Y, Takei T, Takagi T, Sadamitsu T, Harada S, Uchiyama T, Ohbayashi C, Nishiofuku H, Tanaka T, Sho M.
    Liver metastases of a neuroendocrine tumor arising from a tailgut cyst treated with interventional locoregional therapies: a case report and review of the literature on recurrent cases.
    Int Cancer Conf J. 2022 Dec 19;12(2):93-99.
  26. Nakagawa K, Sho M, Fujishiro M, Kakushima N, Horimatsu T, Okada KI, Iguchi M, Uraoka T, Kato M, Yamamoto Y, Aoyama T, Akahori T, Eguchi H, Kanaji S, Kanetaka K, Kuroda S, Nagakawa Y, Nunobe S, Higuchi R, Fujii T, Yamashita H, Yamada S, Narita Y, Honma Y, Muro K, Ushiku T, Ejima Y, Yamaue H, Kodera Y.
    Clinical practice guidelines for duodenal cancer 2021.
    J Gastroenterol. 2022 Dec;57(12):927-941.
  27. Kamitani N, Nakamae I, Yoneda-Kato N, Kato JY, Sho M.
    Preclinical evaluation of pentagamavunone-1 as monotherapy and combination therapy for pancreatic cancer in multiple xenograft models.
    Sci Rep. 2022 Dec 27;12(1):22419.
  28. Nishiwada S, Cui Y, Sho M, Jun E, Akahori T, Nakamura K, Sonohara F, Yamada S, Fujii T, Han IW, Tsai S, Kodera Y, Park JO, Von Hoff D, Kim SC, Li W, Goel A.
    Transcriptomic Profiling Identifies an Exosomal microRNA Signature for Predicting Recurrence Following Surgery in Patients With Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2022 Dec 1;276(6):e876-e885.
  29. Yoshida T, Ogura G, Tanabe M, Hayashi T, Ohbayashi C, Azuma M, Kunisaki C, Akazawa Y, Ozawa S, Matsumoto S, Suzuki T, Mitoro A, Fukunaga T, Shimizu A, Fujimoto G, Yao T.
    Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan.
    Cancer Biol Ther. 2022 Dec 31;23(1):191-200.